Get the Stockscreener App
6.93
6.10%
-0.45
After Hours:
6.90
-0.03
-0.43%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.93, with a volume of 2.15M.
It is down -6.10% in the last 24 hours and up +2.21% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$7.38
Open:
$7.44
24h Volume:
2.15M
Relative Volume:
0.94
Market Cap:
$2.57B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-14.44
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
+9.13%
1M Performance:
+2.21%
6M Performance:
+49.68%
1Y Performance:
-14.66%
1-Day Range:
$6.92
$7.44
1-Week Range:
$6.53
$7.55
52-Week Range:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.93 | 2.73B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
118.65 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.18 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.46 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
489.31 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Bausch Health ticks higher following large director stock purchase - MSN
Is Bausch Health Companies Inc. (BVF) stock a buy before earnings resultsOptions Play & Free Community Supported Trade Ideas - Newser
Will Bausch Health Companies Inc. (BVF) stock profit from AI boomMarket Performance Summary & Accurate Intraday Trading Signals - Newser
Will Bausch Health Companies Inc. stock outperform growth indexesQuarterly Profit Report & Daily Growth Stock Tips - Newser
Can Bausch Health Companies Inc. stock sustain breakout momentumBond Market & Real-Time Stock Entry Alerts - Newser
Will Bausch Health Companies Inc. (BVF) stock sustain uptrend momentum2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
Why Bausch Health Companies Inc. stock could rally strongly2025 Buyback Activity & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-12-04 04:20:11 - Newser
Is Bausch Health Companies Inc. stock resilient to inflation2025 Sector Review & AI Powered Market Entry Ideas - Newser
Is Bausch Health Companies Inc. stock a good hedge against inflation2025 Bull vs Bear & Smart Money Movement Alerts - Newser
John Paulson's Strategic Acquisition in Bausch Health Companies Inc. - GuruFocus
What valuation ratios show for Bausch Health Companies Inc. stockWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Bausch Health Companies Inc. (BVF) stock supported by strong fundamentalsMarket Rally & Long-Term Safe Investment Ideas - Newser
Why pension funds invest in Bausch Health Companies Inc. (BVF) stock2025 Momentum Check & Weekly Breakout Watchlists - Newser
Why Bausch Health Companies Inc. stock remains top ratedEarnings Miss & AI Forecast Swing Trade Picks - Newser
Assessing Bausch Health Companies (NYSE:BHC) Valuation After a 13% YTD Decline and Recent Bounce - Sahm
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business - cnhinews.com
Bausch Health Companies to Present at Cowen Annual Health Care Conference - ACCESS Newswire
Bausch Health Companies (BHC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's Why - MarketBeat
Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments? - Yahoo Finance
How higher bond yields impact Bausch Health Companies Inc. (BVF) stockJobs Report & Short-Term Swing Trade Alerts - Newser
Why analysts maintain buy rating on Bausch Health Companies Inc. (BVF) stockWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Globe and Mail
Bausch Health’s Intriguing Market Moves - StocksToTrade
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Motley Fool
Bausch Health completes acquisition of Chinese aesthetics distributor By Investing.com - Investing.com Australia
Why Are Shares Of Bausch Health Up Today? - Benzinga
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis - ACCESS Newswire
Director buying at Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health completes acquisition of Chinese aesthetics distributor - Investing.com India
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China - ACCESS Newswire
Bausch Health (NYSE:BHC) brings Solta Medical distribution in-house in China - Stock Titan
Acne Treatment Market Size, Scope 2031 by Key Companies- Johnson - openPR.com
Franklin Resources Inc. Has $7.45 Million Stake in Bausch Health Cos Inc. $BHC - MarketBeat
Layoff Tracker: Valneva Terminates 30 Amid Site Closure - BioSpace
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):